Atovaquone and Proguanil Hydrochloride 250 mg/1

Atovaquone and Proguanil Hydrochloride 250 mg/1 is a combination medication used for malaria prevention and treatment. This oral tablet is designed to help manage and prevent malaria, a serious tropical disease.

Atovaquone and Proguanil Hydrochloride is primarily used for the prevention and treatment of malaria, a mosquito-borne disease caused by parasites. This medication is often prescribed for travelers to areas where malaria is common, helping to reduce the risk of infection. It works by interfering with the growth of the parasites that cause malaria, providing a protective effect.

Common effects of Atovaquone and Proguanil Hydrochloride may include nausea, vomiting, diarrhea, and headache. Some users might experience abdominal pain or loss of appetite. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare provider.

Atovaquone and Proguanil Hydrochloride should be used with caution in individuals with severe kidney or liver problems. It is important to follow the prescribed dosage and complete the full course of treatment to ensure effectiveness. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Atovaquone and Proguanil Hydrochloride may interact with certain medications, including antacids, metoclopramide, and drugs that induce liver enzymes. Alcohol consumption should be avoided as it may reduce the effectiveness of the medication. Always consult a healthcare provider before starting any new medication while taking Atovaquone and Proguanil Hydrochloride.